Time To Buy The Dip In Boston Scientific Stock?
Boston Scientific (BSX) stock has fallen by 11.5% in less than a month, from $70.17 on 26th Mar, 2026 to $62.07 now. Should you buy this dip?
Dip buying is a viable strategy for quality stocks that have a history of recovering from dips. As it turns out, BSX stock passes basic quality checks. Historically, the median return for the 12-month period following sharp dips was 16% , with median peak return reaching 24%. We define sharp dip as stock going down 20% or more, in less than 30 day period.
Below, we get into details of historical dips and subsequent returns.
Historical Median Returns Post Dips
- Stronger Bet Than IDEXX Laboratories Stock: DXCM, BSX Deliver More
- Why BSX Could Outperform Stryker Stock
- Why DXCM, BSX Could Outperform Edwards Lifesciences Stock
- Why BSX Stock’s Q1 Beat Is A Lagging Indicator
- DXCM, BSX Look Smarter Buy Than IDEXX Laboratories Stock
- Earn 9.6% Today or Buy BSX 30% Cheaper – It’s a Win-Win
| Period | Past Median Return |
|---|---|
| 1M | 3.1% |
| 3M | -7.5% |
| 6M | 16.2% |
| 12M | 16.0% |
Historical Dip-Wise Details
BSX had 5 events since 1/1/2010 where the dip threshold of -20% within 30 days was triggered
- 24% median peak return within 1 year of dip event
- 200 days is the median time to peak return after a dip event
- -21% median max drawdown within 1 year of dip event
| 30 Day Dip | BSX Subsequent Performance | |||||||
|---|---|---|---|---|---|---|---|---|
| Date | BSX | SPY | 1Y | Peak Return |
Max Drop |
# Days to Peak |
||
| Median | 16% | 24% | -21% | 200 | ||||
| 2042026 | -21% | 1% | -18% | 3% | -21% | 1 | ||
| 11232020 | -21% | 1% | 21% | 38% | -1% | 252 | ||
| 3092020 | -21% | -17% | 16% | 24% | -24% | 177 | ||
| 6042010 | -20% | -12% | 20% | 37% | -11% | 200 | ||
| 3152010 | -21% | 8% | 7% | 15% | -25% | 281 | ||
1Y Refers to 1 year or time since recent dip, whichever is smaller
Boston Scientific Passes Basic Financial Quality Checks
Revenue growth, profitability, cash flow, and balance sheet strength need to be evaluated to reduce the risk of a dip being the sign of a deteriorating business situation.
| Quality Metrics | Value | Quality Check |
|---|---|---|
| Revenue Growth (LTM) | 19.9% | Pass |
| Revenue Growth (3-Yr Avg) | 16.6% | Pass |
| Operating Cash Flow Margin (LTM) | 22.6% | Pass |
| Leverage (see below) | – | Pass |
| => Interest Coverage Ratio | 10.7 | |
| => Cash To Interest Expense Ratio | 5.6 |
Not sure if you can take a call on BSX stock? Consider portfolio approach
The Right Way To Invest Is Through Portfolios
Individual stocks are unpredictable. A smart portfolio helps you invest, limits downside shocks, and provides upside exposure.
Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.